0fa708099edf4041a302151bce05b87e35dae26af4d9477da92674b38e89acfb3a0441b18a954ae29a3ba79232acd5703bd50d39be604bf08ddc4a127557bda588c92729d9694046aa79b0670bf3fd979298e3a218134f6fabf940e6a915a375c765a4d6fa9942e9b123f9f3cdf69c4fcdc85745f82c4ac6b8e1c1b6454e8016e348552a52924be5b636231ab95d95bbf0c945b7ea504ec4989a3edcbb55fe9f
agent
Common Genetic Variants Contribute to Risk of Transposition of the Great ArteriesSpatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathyEpicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathyGene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelingSingle-cell transcriptomics provides insights into hypertrophic cardiomyopathyPITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathyProtein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related CardiomyopathyCardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturationThe phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapyPhospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
author
type
label
Cornelis J Boogerd
firstName
Cornelis J